Zobrazeno 1 - 10
of 29
pro vyhledávání: ''
Publikováno v:
Oncologist
Chronic myelomonocytic leukemia (CMML) is a hematologic malignancy characterized by absolute monocytosis, one or more lineage dysplasia, and proliferative features including myeloid hyperplasia, splenomegaly, and constitutional symptoms. Because of v
Autor:
Edward Laane, Iordanis Gravanis, Pieter de Graeff, Petra Schmitt, Paula van Hennik, Christian Gisselbrecht, Jan Mueller-Berghaus, Kyriaki Tzogani, Francesco Pignatti, Lothar Bergmann, Tomas Salmonson
Publikováno v:
The Oncologist. 21:102-109
Background On October 25, 2012, a conditional marketing authorization valid throughout the European Union (EU) was issued for brentuximab vedotin for the treatment of adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL) and for the
Publikováno v:
The Oncologist. 20:806-811
Background. Posterior reversible encephalopathy syndrome (PRES) is characterized by neurologic symptoms with typical lesions on neuroimaging and may be associated with chemotherapy and immunosuppressive agents used in patients with cancer. We describ
Autor:
José Luis Herrera-Garza, Cesar Daniel Villarreal-Villarreal, David Gómez-Almaguer, Olga G. Cantú-Rodríguez, Alberto Carlos Heredia-Salazar, Homero Gutiérrez-Aguirre, José Carlos Jaime-Pérez, Consuelo Mancías-Guerra
Publikováno v:
The Oncologist. 20:386-392
Background and Objective. Hematopoietic stem cell transplantation (HSCT) in developing countries is cost-limited. Our primarygoalwastodeterminethecoststructurefortheHSCT program model developed over the last decade at our public university hospital a
Autor:
Joseph J. Fins, Richard R. Furman, Meredith Stark, Ellen C. Meltzer, Cathleen A. Acres, Natalia S. Ivascu
Publikováno v:
The Oncologist. 19:985-989
Objective. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) for cardiopulmonary support offers survival possibilities to patients who otherwise would succumb to cardiac failure. Often referred to as “a bridge to recovery,” involving a v
Autor:
Jesús F. San-Miguel, Roman Hájek, Hartmut Goldschmidt, Meletios A. Dimopoulos, Javier de la Rubia, Michel Delforge, Michele Cavo, Hareth Nahi, Faith E. Davies, Antonio Palumbo, Mario Boccadoro, Philippe Moreau, Hermann Einsele, Pia Sondergeld, Joan Bladé, Pieter Sonneveld, Thierry Facon, Heinz Ludwig, Torben Plesner, Gareth J. Morgan
Publikováno v:
Oncologist
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Ludwig, H, Sonneveld, P, Davies, F, Bladé, J, Boccadoro, M, Cavo, M, Morgan, G, de la Rubia, J, Delforge, M, Dimopoulos, M, Einsele, H, Facon, T, Goldschmidt, H, Moreau, P, Nahi, H, Plesner, T, San-Miguel, J, Hajek, R, Sondergeld, P & Palumbo, A 2014, ' European perspective on multiple myeloma treatment strategies in 2014 ', Oncologist, vol. 19, no. 8, pp. 829-844 . https://doi.org/10.1634/theoncologist.2014-0042
Oncologist, 19(8), 829-844. AlphaMed Press
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Ludwig, H, Sonneveld, P, Davies, F, Bladé, J, Boccadoro, M, Cavo, M, Morgan, G, de la Rubia, J, Delforge, M, Dimopoulos, M, Einsele, H, Facon, T, Goldschmidt, H, Moreau, P, Nahi, H, Plesner, T, San-Miguel, J, Hajek, R, Sondergeld, P & Palumbo, A 2014, ' European perspective on multiple myeloma treatment strategies in 2014 ', Oncologist, vol. 19, no. 8, pp. 829-844 . https://doi.org/10.1634/theoncologist.2014-0042
Oncologist, 19(8), 829-844. AlphaMed Press
The treatment of multiple myeloma has undergone significant changes and has resulted in the achievement of molecular remissions, the prolongation of remission duration, and extended survival becoming realistic goals, with a cure being possible in a s
Autor:
Richard Leblanc, Faraz Zaman, Darrell White, Donna E. Reece, Kevin W. Song, Khalid Mezzi, Ade Olujohungbe, Andrew Belch
Publikováno v:
The Oncologist. 18:611-618
Multiple myeloma is a malignancy of B cells characterized by accumulation of abnormal plasma cells in the bone marrow. In the past 20 years, the use of high-dose therapies and novel agents has resulted in significant and meaningful improvements in su
Autor:
Pamela S. Hinds, Diane L. Fairclough, Wendy Pelletier, Kristin Stegenga, Melissa A. Alderfer, Rebecca D. Pentz
Publikováno v:
The Oncologist. 17:881-885
Learning Objectives After completing this course, the reader will be able to: When the alternative to medical treatment is likely death, ask parents and children whether they agree to the medical plan rather than suggesting they are sharing in “a d
Publikováno v:
The Oncologist. 17:694-707
Although patients with B-cell non-Hodgkin's lymphoma (NHL) usually respond to initial conventional chemotherapy, they often relapse and mortality has continued to increase over the last three decades in spite of salvage therapy or high dose therapy a
Autor:
Wai M. Tai, Yatanar Soe, Choon H. Thng, Han Chong Toh, Wan T. Lim, Swee Peng Yap, Whay Kuang Chia, Li Sun, Who W. Wang, Eng H. Tan
Publikováno v:
The Oncologist. 15:1192-1197
We present a case of a patient with metastatic nasopharyngeal carcinoma who failed two lines of palliative combination chemotherapy and was treated with allogeneic nonmyeloablative stem cell transplantation (NST). This patient achieved a durable tumo